Women with higher parity have a lower risk of ovarian cancer possibly because of pregnancy hormones, but the specific effect of different pregnancy hormones on ovarian cancer risk is not clear. Some clarification might be gained by considering situations where hormone levels vary between pregnancies. Study participants from an Australian population-based, case-control study of epithelial ovarian cancer (2001)(2002)(2003)(2004)(2005) completed a reproductive/lifestyle questionnaire. The authors included 1,203 cases and 1,286 controls with at least 1 birth and, using multiple logistic regression, calculated odds ratios and 95% confidence intervals to investigate the effects of pregnancy-related factors on cancer risk. Women who had 1 or more preterm births had higher risks of ovarian cancer than those who had only full-term births (odds ratio (OR) ¼ 1.48, 95% confidence interval (CI): 1.02, 2.15). The authors also found that bearing only boys was associated with a 2-fold increased risk of mucinous ovarian cancer (OR ¼ 2.19, 95% CI: 1.15, 4.17). There was no association between multiple pregnancy and ovarian cancer (for any multiple pregnancy vs. only singleton pregnancies: OR ¼ 1.22, 95% CI: 0.74, 2.02). The results suggest that pregnancies associated with differing hormonal milieux have different effects on ovarian cancer risk and that some of these associations may vary with histologic subtype. multiple birth offspring; ovarian neoplasms; premature birth Abbreviations: CI, confidence interval; OR, odds ratio.
Increasing parity has consistently been associated with a decreased occurrence of epithelial ovarian cancer. The reason for the association is unknown and, although frequently attributed to the months of respite from ovulation, this cannot fully explain the magnitude of the protective effect (1) (2) (3) . It is thus likely that this is also at least partly due to the hormonal environment of pregnancy (1) (2) (3) . The effects of specific pregnancy hormones on ovarian cancer risk are not well understood. We postulated that some clarification might be gained by considering the effects of the substantial variation in the hormonal milieu that occurs across the course of a pregnancy, as well as between pregnancies with different outcomes. For example, the levels of progesterone, estriol, and prolactin rise rapidly in the later weeks of pregnancy, such that women who have full-term births experience much higher levels of these hormones than women who have preterm births. Women who carry male fetuses experience lower levels of human chorionic gonadotrophin (4, 5) and possibly different levels of sex steroid hormones, than woman carrying female fetuses (6) (7) (8) . Women with twin gestations may also be exposed to higher levels of progesterone than women with singleton pregnancies (9) .
Relatively few studies have considered the effects of differing gestational hormonal environments on the subsequent risk of ovarian cancer. In relation to gestational length, 1 study found that, compared with women with term births, women who delivered before 36 weeks' gestation had a 2-fold increase in their risk of ovarian cancer (10) . In a smaller study, the same group found that women who delivered postterm (42 weeks' gestation) were at increased risk of ovarian cancer (11) . The results of studies investigating the effect of sex of offspring on ovarian cancer risk have been inconsistent. Some have suggested that women who have given birth only to girls have an increased risk of ovarian cancer compared with women who have 1 or more boys (12, 13) , with 1 group finding this effect to be restricted to endometrioid ovarian cancers (14) , while others found no association between the sex of offspring and ovarian cancer occurrence (15) . Although a number of studies have examined the relation between twin births and ovarian cancer and there have been suggestions that a twin birth might afford greater protection against ovarian cancer than a singleton birth (14, (16) (17) (18) (19) (20) , the associations reported have been small and mostly not statistically significant.
We have used data from a large Australian case-control study to evaluate these relations in detail and to assess variation by histologic subtype of ovarian cancer.
MATERIALS AND METHODS
The Australian Ovarian Cancer Study (AOCS) was an Australia-wide, population-based, case-control study conducted between January 2002 and June 2005. Women aged 18-79 years diagnosed with epithelial ovarian cancer during this period were ascertained through treatment clinics and state cancer registries by research nurses.
A total of 3,550 women with suspected ovarian cancer were identified. Of these, 307 died before contact could be made, the treating doctor refused contact with 133, and 194 women could not be contacted. A further 171 women were excluded on the basis of language difficulties (n ¼ 70), mental incapacity (n ¼ 35), and illness (n ¼ 66). With their treating doctor's permission, the remaining 2,745 women were invited to participate and, of these, 2,319 (84%) agreed to take part. Most were recruited prior to surgery (and therefore prior to histopathologic diagnosis) to allow collection of fresh tumor tissue. After surgery, pathology reports were obtained for all women; 608 were excluded because their final diagnosis was a benign, nonepithelial, or metastatic tumor and not primary epithelial ovarian cancer, 25 were excluded because their cancer was first diagnosed before the start of the study period, and 1 woman was excluded because she was not an Australian resident at the time of her diagnosis. Two researchers independently abstracted information on tumor site, histologic subtype, and tumor behavior (invasive vs. borderline) from the diagnostic histopathology reports. Discrepancies were resolved by consensus. To check the quality of the abstracted data, the pathology reports and full set of diagnostic slides for a sample of 200 women were reviewed by gynecologic pathologists; agreement with the abstracted data was greater than 95% for tumor subtype and site and 99% for tumor behavior. Of the final 1,685 eligible participants, 1,591 (94%) returned a questionnaire. The median time between histopathologic diagnosis and completion of the questionnaire was 12 weeks.
We randomly selected potential control women from the Australian Electoral Roll (enrolment to vote is compulsory in Australia), frequency matched to the case series by age (in 5-year groups) and state of residence. Of the 3,613 women contacted and invited to participate, 171 women were excluded because of illness (n ¼ 63), language difficulties (n ¼ 97), and death during the recruitment process (n ¼ 11). Of the remaining 3,442 women, 1,613 returned a questionnaire (47%). Six reported a history of ovarian cancer, and 99 reported a previous bilateral oophorectomy and thus were excluded from the present study, leaving 1,508 population controls.
All participants were asked to complete a questionnaire that included detailed questions about reproductive history. For each of their pregnancies, women were asked to record the following information: the date the pregnancy ended; the duration of the pregnancy; whether the pregnancy was a singleton or multiple pregnancy; the outcome of the pregnancy (livebirth, stillbirth, miscarriage/termination, or ectopic); and the sex of the child. A small number of women (81 cases, 30 controls) who responded to a shorter telephone version of the questionnaire, which omitted these detailed pregnancy-related questions, have been excluded from the current analyses. Covariate information was missing for less than 2% of cases and controls.
We excluded events or behaviors of interest that had occurred in the 12 months prior to diagnosis for cases or the 12 months prior to first approach for controls, because it is possible that preclinical disease in cases may have influenced recent personal factors of interest.
Women were asked to specify the duration of each pregnancy in months. We considered gestations of less than 6 months' duration to be incomplete pregnancies and excluded these from the current analyses, because most previous studies have found that incomplete pregnancies have little influence on ovarian cancer risk (21) (22) (23) . Only parous women (i.e., those who had experienced childbirth) were included, giving 1,203 cases and 1,286 controls for analysis. A birth is considered preterm if it occurs before 37 weeks' gestation, but information on duration of gestation was available only in months. Pregnancies of 6 or 7 months' duration were considered to be ''preterm'' births, while those of 8 or more months' gestation were considered to be ''term'' births. We included 8-month pregnancies as term births, because we felt that many pregnancies described as 8 months would, in practice, have been 36-38 weeks and, thus, hormonally they would be more similar to a 9-month pregnancy than a 7-month pregnancy. For each parous woman, the durations of all pregnancies resulting in a birth (i.e., both preterm and term births but excluding incomplete pregnancies) were summed to create a variable representing total months of eligible pregnancy. Analyses were adjusted for parity, but to ensure that the results were not compromised by residual confounding by parity, we also conducted analyses stratified by parity. There were insufficient women to conduct stratum-specific comparisons for those with more than 3 births. Women who had experienced a multiple birth were included only in the analyses specific to multiple births, because of the different hormonal environment of a multiple versus a singleton pregnancy.
Because evidence suggests that the various histologic subtypes of ovarian cancer may have different etiologies (24) (25) (26) , we also aimed to investigate subtype-specific effects. However, the number of women who had experienced a preterm or multiple birth was small, so subtype analyses were undertaken only in relation to the sex of the offspring. Invasive and borderline mucinous cancers were considered together in subtype-specific analyses, as it is likely that invasive mucinous cancers arise from borderline mucinous cancers, while borderline and invasive serous cancers were considered separately as evidence suggests that these are separate neoplastic entities (27) .
Effects were estimated by odds ratios with 95% confidence intervals. Tests of statistical significance were 2 sided. Unconditional multiple logistic regression was used to simultaneously adjust for potential confounding factors. With respect to analyses related to preterm births, all models, unless otherwise stated, included a term for age, duration of hormonal contraceptive use, level of education, smoking status, and body mass index. Other potential confounders, such as state of residence (a matching factor), number of incomplete pregnancies, breastfeeding duration, alcohol intake, menopausal status, use of hormone replacement therapy, and tubal ligation, which did not change risk estimates by more than 10%, were not included in the final models. The models for analyses concerning the sex of offspring and multiple gestations included terms for age, contraceptive use, family history of breast or ovarian cancer in a firstdegree relative, tubal sterilization, hysterectomy, and education. To investigate trends for ordinal variables, the median value for each category was used in a continuous term, and the associated P value was assessed (values of <0.05 were considered statistically significant). Where appropriate, cancer subtypes were compared by using polytomous logistic regression. All analyses were conducted with SAS, version 9.1, statistical software (SAS Institute, Inc., Cary, North Carolina).
This study was approved by the human research ethics committees at the Peter MacCallum Cancer Centre, Queensland Institute of Medical Research, University of Melbourne; the cancer councils of New South Wales, South Australia, and Victoria; the Cancer Foundation of Western Australia; and all participating hospitals.
RESULTS
The characteristics of the women who had at least 1 birth (1,203 cases and 1,286 controls) are summarized in Table 1 .
Among the cases, 77% of the cancers were invasive and 23% borderline. Among the invasive cancers, 66% were serous, 12% endometrioid, 3% mucinous, 7% clear cell, and 12% other subtypes. Among the borderline cancers, 49% were serous, 47% were mucinous, and 4% other subtypes.
The associations between duration of gestation and risk of epithelial ovarian cancer are summarized in Table 2 . Among all parous women combined, women who had ever had a preterm birth had a 50% increase in risk of ovarian cancer (odds ratio (OR) ¼ 1.48, 95% confidence interval (CI): 1.02, 2.15) compared with women who had only had full-term births. Among women with 1 birth, there was no evidence that preterm births were linked to ovarian cancer risk, although the number of women who had a single birth that was preterm was very small and the associated confidence intervals wide (for ever vs. never had a preterm birth: OR ¼ 0.82, 95% CI: 0.20, 3.35). In women who had 2 or 3 births, ever having a preterm birth was associated with a 60% and 90% increase in risk of ovarian cancer, respectively, although these estimates were not statistically significant. Ovarian Cancer and Pregnancy-related Factors 609
We also considered women's total months of eligible pregnancy (singleton pregnancies lasting 6 months). Among women with 2 births, those who had 16 months or less of pregnancy rather than the usual 18 months (i.e., two 9-month pregnancies) had a 2-fold increased risk of ovarian cancer (OR ¼ 2.00, 95% CI: 1.00, 3.99). Among women with 3 births, those who had 24 months or less of pregnancy rather than the usual 27 months (i.e., three 9-month a ''Births'' were deliveries after 6 or more months of gestation (excludes women with twins and higher-order multiples).
b Adjusted for age (in years), educational level (high school, technical, university), hormonal contraceptive use (never, <5 years, 5 years), body mass index (<25, 25-29.9, 30 kg/m 2 ), and smoking status (never, former, current).
c Additionally adjusted for parity (1, 2, 3, 4, 5 births). d ''Eligible'' pregnancies were those pregnancies resulting in a birth.
pregnancies) also had a statistically significant increase in ovarian cancer risk (OR ¼ 2.4, 95% CI: 1.06, 5.40). There were insufficient numbers of women who had had only preterm births (9 cases and 4 controls) to determine whether their risk of ovarian cancer differed from that of nulliparous women. Table 3 summarizes the findings for the associations between the sex of offspring and ovarian cancer. Overall, there was a suggestion that women who had only boys, compared with only girls, had a small increase in risk of ovarian cancer (OR ¼ 1.22, 95% CI: 0.94, 1.60). When we stratified by number of births, we found that the relation appeared stronger for women who had 2 boys, compared with those who had 2 girls (OR ¼ 1.67, 95% CI: 1.11, 2.51), but was not apparent for women who had 3 boys, compared with those who had 3 girls (OR ¼ 0.79, 95% CI: 0.42, 1.51). These results were largely driven by the invasive serous cancers, which comprised the majority of cancers (58%), but when we stratified by histologic subtype, a more pronounced pattern was apparent for mucinous cancers. Among all parous women, those who had only boys had a 2-fold increase in risk of mucinous ovarian cancers (invasive and borderline combined) (OR ¼ 2.19, 95% CI: 1.15, 4.17), and a significant trend of increasing risk with increasing numbers of male births was apparent (P trend ¼ 0.003). This linear trend for mucinous cancers was significantly different from those for each of the other subtypes (P 0.01) apart from clear cell cancers, where comparisons were limited by small numbers. Similar patterns were seen among women with 1, 2, or 3 births, with significant trends of increasing risk of mucinous cancers with increasing numbers of male births (P trend ¼ 0.006 for 2 male births; P trend ¼ 0.03 for 3 male births). There were no notable associations between the sex of offspring and the development of other ovarian cancer subtypes (Table 3) .
We also investigated the relation between multiple births and ovarian cancer but did not find a significant link among either all parous women (for ever vs. never had a multiple pregnancy, additionally adjusted for use of fertility drugs: OR ¼ 1.22, 95% CI: 0.74, 2.02) or women stratified by numbers of births (data not shown). However, only 1% of cases (n ¼ 33) and 1% of controls (n ¼ 32) had ever had a multiple birth.
DISCUSSION
Our findings suggest that pregnancies associated with differing hormonal milieux have differing effects on ovarian cancer risk and that some of these associations may vary with histologic subtype. We found that women who have preterm births appear to have a greater risk of ovarian cancer compared with women who have only full-term births. In addition, our results suggest that risk, particularly of mucinous ovarian cancer, is influenced by the sex of the offspring, with greater risks associated with bearing males. We did not find an association between multiple births and ovarian cancer occurrence, although in our study there were only relatively small numbers of women who had had a multiple birth (1% in controls, which is comparable to rates in the general population (28)).
Our findings in relation to gestational length are in keeping with 1 previous study by Mucci et al. (10) . Like us, these authors reported that women who had preterm deliveries were at an increased risk of ovarian cancer compared with women who had only full-term pregnancies. In a smaller study (cases ¼ 316), the same group found that women with postterm deliveries (42 weeks) had increased risks of ovarian cancer (11) . In our study, there were too few women with postterm deliveries to adequately assess this relation. For similar reasons, we were also unable to determine whether women who had only preterm births had a lower risk of ovarian cancer than did nulliparous women. Future studies that have the power to examine this question may contribute substantially to our understanding of the mechanisms by which pregnancy influences risk of ovarian cancer.
Several studies have investigated the association between the sex of offspring and ovarian cancer, but the results have been mixed. Among studies that considered singleton pregnancies, 2 found no difference in ovarian cancer risk according to the sex of the offspring (14, 15); 1 found that women having only boys had a decreased risk of ovarian cancer (13) , while the final study found that the greatest protection among women who had 2 births was for those who had 1 boy and 1 girl rather than 2 of the same sex (12) . In contrast, our results suggest that women who give birth to boys have an increased risk of ovarian cancer compared with those giving birth to girls, but this effect is largely restricted to mucinous ovarian cancer. Only 1 other study appears to have considered histologic subtype in its analyses, and the authors of that study found that the risk of endometrioid cancers was increased among women who gave birth to girls, but they found no consistent associations with the other histologic subtypes (14) . Larger studies, or studies pooling multiple data sets, are required to clarify the effect of the sex of offspring on risk of the various histologic subtypes of ovarian cancer.
Strengths of the current study include the populationbased design; the large number of cases, which allowed some investigation of subtype-specific effects; and the detailed information available on pregnancy-related factors. One limitation is that 14% of women ascertained as having ovarian cancer were too ill to participate or had died. Stratification by stage of disease at diagnosis did not suggest that the associations varied appreciably between those with stage I/II and those with stage III/IV disease; however, our result may not be applicable to women who have rapidly fatal disease. Another limitation of our study was the relatively low participation rate of 47% among controls. It was thus possible that those who took part were systematically different from those who did not. This might be of particular importance, because preterm birth is associated with factors such as socioeconomic status, smoking history, and body mass index (29) that might differ between those willing to participate in health-related studies compared with those less willing. We assessed this issue by comparing data from our control group with data from the 2001 Australian National Health Survey, a national population-based survey with a response rate of approximately 90% (30) . Distributions of educational level, body mass index, parity, and ever versus never smoking among our controls were almost identical to those from the National Health Survey, suggesting that bias among our control group is an unlikely explanation of our results. We have made multiple comparisons, and thus it is possible that our findings are due to chance. However, the consistency that we found between the results for women with 2 or 3 children and the dose-response patterns that we saw for sex of offspring provides some reassurance in this regard. Our findings in relation to gestational length are in keeping with 2 prevailing theories of ovarian carcinogenesis. According to the incessant ovulation hypothesis (31), the breakdown and subsequent repair of the ovarian epithelium that occur with monthly ovulation may, over many years, result in neoplastic transformation. Higher numbers of ovulations are thus associated with an increased risk of ovarian cancer. Compared with preterm births, full-term births may slightly reduce the number of ovulations to which an ovary is exposed. However, the differences between women with and without preterm births would be small (generally from 2 to 3 months of pregnancy and thus ovulations suppressed in our data), and incomplete pregnancies, which would prevent similar numbers of ovulations, have not been shown to decrease the risk of ovarian cancer (21) (22) (23) . A second hypothesis that may better account for our findings suggests that pregnancy may have the effect of clearing damaged epithelial cells from the ovary (32)-an effect perhaps mediated by progesterone (1, 33) . Progesterone levels rise rapidly in the latter weeks of pregnancy, such that women delivering at term are exposed to substantially higher levels than those who deliver preterm. It may be, therefore, that exposure to high levels of progesterone in the last weeks of pregnancy contributes substantially to the risk reduction associated with pregnancy, such that preterm pregnancies do not have the same protective effect.
Women bearing twins are thought to experience higher levels of progesterone than women with singleton pregnancies (9) and, thus, our findings in relation to multiple pregnancies do not provide additional support for the progesterone hypothesis. However, women with multiple pregnancies are much more likely to deliver prior to term (approximately half of such women in our study), thereby potentially moderating their overall exposure to progesterone. In addition, the small number of study participants exposed to multiple pregnancy precludes firm conclusions being drawn from our results.
Differences in the levels of hormones that pregnant women experience might also account for the differences in risk associated with the sex of offspring. For example, androgen exposure has been postulated as a possible etiologic factor in ovarian carcinogenesis (1) . Women carrying male fetuses may be exposed to higher levels of androgens than women carrying female fetuses (7, 34) , although this finding is not consistent (5, 35) . A more consistent finding is that human chorionic gonadotrophin levels are higher in women bearing female fetuses than in those carrying male fetuses, particularly in the last trimester of pregnancy (4, 5) . It has been found that human chorionic gonadotrophin inhibits proliferation in benign, borderline, and malignant ovarian epithelial cell lines (36) , providing a possible explanation for the apparent protective effect that we have observed of bearing a girl compared with bearing a boy. Why this effect would be specific to the mucinous subtype is unclear, although epidemiologic evidence (24) (25) (26) suggests that mucinous cancers are etiologically distinct from the other histologic subtypes.
In conclusion, our work suggests that pregnancies associated with differing hormonal milieux differ in their influence on ovarian cancer risk. Confirmation of our findings in other studies is required and may contribute to our understanding of the mechanisms by which pregnancy decreases the risk of ovarian cancer.
